Centre orders diversion of Remdesivir stocks to four States
The Hindu
T.N. seeks uninterrupted supply, amid rising infections
The Tamil Nadu government has sought the intervention of the Union Health Minister to ensure an uninterrupted supply of Remdesivir, the anti-viral drug used in the treatment of COVID-19. The decision follows an order issued by the Central Drugs Standard Control Organisation (Enforcement Division) to six manufacturers of Remdesivir (Cipla, Dr. Reddy’s Laboratories, Zydus Cadila, Jubilant Life Sciences, Hetero and Mylan Laboratories) on the supply of the drug. “In light of concerns over the availability of Remdesivir in major States dealing with COVID-19 cases, especially Maharashtra, Madhya Pradesh, Chhattisgarh and Gujarat, you are requested to rush the stock to these States immediately and action taken in this regard should be intimated...,” Drugs Controller-General of India V.G. Somani said in the April 10 order.More Related News